Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Stock Short Interest Report for October

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) was the recipient of a significant increase in short interest during the month of October. As of October 30th, there was short interest totaling 192,457 shares, an increase of 1,629.0% from the October 15th total of 11,131 shares. Based on an average trading volume of 648 shares, the short-interest ratio is presently 297.0 days.

Analyst Ratings Changes

FSPKF has been the topic of several recent analyst reports. Royal Bank Of Canada raised Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a research note on Tuesday, September 15th. Citigroup raised Fisher & Paykel Healthcare to a “buy” rating in a research report on Thursday, September 10th. Two analysts have rated the stock with a Buy rating. According to MarketBeat.com, the company presently has an average rating of “Buy”.

Fisher & Paykel Healthcare Stock Performance

Shares of OTCMKTS FSPKF remained flat at $26.99 during midday trading on Tuesday. Fisher & Paykel Healthcare has a 52-week low of $19.01 and a 52-week high of $28.09. The firm’s 50 day moving average price is $26.39 and its 200 day moving average price is $23.79.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and home healthcare. Its technologies are designed to help patients breathe more comfortably and effectively across hospital and home settings. The company’s product portfolio includes respiratory humidification systems, nasal high-flow therapy products, continuous positive airway pressure (CPAP) and noninvasive ventilation masks, as well as related circuits, interfaces and consumables.